Anti-Cancer Drug Design

Prevention of adriamycin-induced mdrl gene amplification and expression in mouse leukemia cells by simultaneous treatment with the anti-recombinogen bromovinyldeoxyuridine
pp. 307-312(6)
Authors: Fahrig, R; Steinkamp-Zucht, A; Schaefer, A

Synthesis, DNA binding and cytotoxicity of isohelical DNA groove binding platinum complexes
pp. 313-322(10)
Authors: Wheate, NJ; Webster, LK; Brodie, CR; Grant Collins, J

Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells
pp. 323-330(8)
Authors: Engman, L; Kanda, T; Gallegos, A; Williams, R; Powis, G

Role of crown-like side chains in the biological activity of substituted-phenoxazone drugs
pp. 331-338(8)
Authors: Karawajew, L; Glibin, EN; Maleev, VY; Czerwony, G; Dörken, B; Davies, DB; Veselkov, AN

Synthesis and cytotoxic activity of carboxamide derivatives of benzimidazo[2,1-a]isoquinoline and pyrido[3′,2′:4,5]imidazo[2,1-a]isoquinoline
pp. 339-346(8)
Authors: Deady, LW; Rodemann, T; Finlay, GJ; Baguley, BC; Denny, WA

The abnormal cytotoxicities of 2,5-diaziridinyl-1,4-benzoquinone-3-phenyl esters
pp. 347-360(14)
Authors: Di Francesco, AM; Hargreaves, RHJ; Wallace, TW; Mayalarp, SP; Hazrati, A; Hartley, JA; Butler, J

Antineoplastic agents 442. Synthesis and biological activities of dioxostatin
pp. 361-371(11)
Authors: Pettit, GR; Lippert, JW; Boyd, MR; Verdier-Pinard, P; Hamel, E

Structural requirements for the formation of anthracycline-DNA adducts
pp. 373-386(14)
Authors: Cutts, SM; Parker, BS; Swift, LP; Kimura, K-i; Phillips, DR

Erratum. Synthesis and antimelanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol
pp. 387-387(1)
Authors: Lant, NJ; McKeown, P; Kelland, LR; Rogers, PM; Robins, DJ